Alya Sample Clauses

Alya. The purpose of Alya is to perform Cardiac Computational Mechanics simulations, from tissue to organ level. FEM-based fluid-electro-mechanical coupling solver, specifically designed for the efficient use of supercomputing resources. Non-clinical research ✔ Clinical research ✔ Clinical decision support ✔ Drug discovery Design & optimisation ✔ In silico clinical trialsPersonal health forecasting Contact email: xxxxxxx.xxxxxxx@xxx.xx Estimated users at M0: 30 internal and 20 external Estimated users at M24: 35 internal and 30 external Estimated users at M36: 40 internal and 40 external (IMPORTANT NOTE: as Alya is used in different domains, the number of users is the grand total) URL: xxxxx://xxx.xxx.xx/research-and-development/software-and-apps/software-list/alya User manual: xxxxxxx.xxxxxxx@xxx.xx End user name Xxxxxx Xxxxxxxxx’x group Xxxxx Xxxxxx’x group JR Cebral’s group ELEM Biotech Dr. Xxxxxxx Xxxxxxxx's group Affiliation UOXF Universitat Xxxxxx Xxxxx Xxxxxx Xxxxx University - University of Strathclyde Application area Cardiac modelling Cardiac modelling Vascular simulations (aneurisms) Cardiovascular modelling, respiratory system, cerebro-spinal fluid Cardiovascular modelling of the right side of the heart No. of associated users 6 5 2 3 1 Target use Research Research / educational Research Commercial, research Research Improvements implemented New models, efficiency, etc. N/A Efficiency Efficiency, models, deployment, etc. N/A Impact Papers Papers Papers Product design, media release, papers N/A yet Use of any e- infrastructure available via CompBioMed BSC and EPCC BSC BSC BSC BSC
AutoNDA by SimpleDocs
Alya. Alya, developed by the team of Xxxxxxx Xxxxxxx and Xxxxxxxxx Xxxxxxxx at the Barcelona Supercomputing Centre, performs multi-scale, multi-physics biomechanical simulations. The specialties of Alya regarding biomedical sciences include cardiac electro-mechanic-flow simulations, from ion-channel kinetics up to organ level; and simulations of the respiratory system, particularly focusing on particle deposition. The simulations involve the solution of mathematical models at different scales using a FEM-based approach. Alya has been specifically optimised for the efficient use of supercomputing resources and does not employ external libraries. Within CompBioMed, our work is to collaborate with other partners (notably Oxford, UCL and SURF) setting up cardiovascular simulation scenarios on large-scale systems and supercomputers. BSC’s role is not only to research improving the accuracy and reach of our simulation platform, but also to make it more efficient in heterogeneous supercomputers, always with the exascale era in mind. Additionally, due to its versality, Alya is a paradigm of the three patterns: monlothic single physics applications, coupled multiphyscis (either Xxxx-Xxxx or Alya with other codes) and ensemble runs for, for instance, massive in-silico clinical trials. We consider that the only way of achieving these two objectives is by knowing deeply the architectures, porting the algorithms to them to get the best performance possible and optimizing all possible levels: core, chip, node and supercomputer (see D2.
Alya. Alya, developed by the team of Xxxxxxx Xxxxxxx and Xxxxxxxxx Xxxxxxxx at the Barcelona Supercomputing Centre, performs multi-scale, multi-physics biomechanical simulations. The specialties of Alya regarding biomedical sciences include cardiac electro-mechanic-flow simulations, from ion-channel kinetics up to organ level; and simulations of the respiratory system, particularly focusing on particle deposition. The simulations involve the solution of mathematical models at different scales using a FEM-based approach. Alya has been specifically optimised for the efficient use of supercomputing resources and does not employ external libraries. Alya is available for use by research scientists on MareNostrum, XXXXXX, and Xxxxxxxxx; for clinical and industrial users, BSC recommends users access it as a service, due to the complexity involved with setting up simulations. To this purpose BSC has launched a spin- off (ELEM Biotech [5]) that will provide commercial software-as-a-service to medical device, pharmaceutical and biomedical industries using Alya.
Alya. Application description Technical specifications HPC usage and parallel performance
Alya 

Related to Alya

  • meminta nasihat daripada Pihak Xxxxxx dalam semua perkara berkenaan dengan jualan lelongan, termasuk Syarat-syarat Jualan (iii) membuat carian Hakmilik Xxxxx xxxxxx rasmi di Pejabat Tanah xxx/atau xxxx-xxxx Pihak-pihak Berkuasa yang berkenaan xxx (iv) membuat pertanyaan dengan Pihak Berkuasa yang berkenaan samada jualan ini terbuka kepada semua bangsa atau kaum Bumiputra Warganegara Malaysia sahaja atau melayu sahaja xxx juga mengenai persetujuan untuk jualan ini sebelum jualan lelong.Penawar yang berjaya ("Pembeli") dikehendaki dengan segera memohon xxx mendapatkan kebenaran pindahmilik (jika ada) daripada Pihak Pemaju xxx/atau Pihak Tuanpunya xxx/atau Pihak Berkuasa Negeri atau badan-badan berkenaan (v) memeriksa xxx memastikan samada jualan ini dikenakan cukai. HAKMILIK : Hakmilik strata bagi hartanah ini masih belum dikeluarkan HAKMILIK INDUK / NO. LOT : Pajakan Negeri 35263, Lot No.29096 MUKIM/DAERAH/NEGERI : Setapak / Kuala Lumpur / Wilayah Persekutuan Kuala Lumpur PEGANGAN : Pajakan selama 82-tahun berakhir pada 08/08/2085 KELUASAN LANTAI : 81.104 meter persegi ( 873 kaki persegi ) PEMAJU/PENJUAL : Mega Planner Jaya Sdn Bhd (326287-W)(Dalam Likuidasi) TUANPUNYA : Datuk Bandar Kuala Lumpur PEMBELI : Xxxxxxxx Bin Xxxxx @ Xxxx BEBANAN : Diserahhak kepada RHB Bank Berhad [196501000373 (6171-M)] Hartanah tersebut terletak di tingkat 9 pada bangunan apartment 14-tingkat terletak di Melati Impian Apartment, Setapak Fasa 1, Kuala Lumpur. Hartanah tersebut adalah sebuah unit apartment 3 xxxxx dikenali sebaga Xxxxx Pemaju No. 9, Tingkat No.9, Pembangunan dikenali sebagai Melati Impian Apartment Setapak Fasa 1, Kuala Lumpur xxx mempunyai alamat surat-xxxxxxxx xx Xxxx Xx. 0-0, Xxxxxx Impian Apartment, Xxxxx 0/00X, Xxxxx Xxxxxx, 00000 Xxxxx Xxxxxx, Xxxxxxx Xxxxxxxxxxx Xxxxx Xxxxxx. Harta ini dijual “keadaan seperti mana sediada” dengan harga rizab sebanyak RM 300,000.00 (RINGGIT MALAYSIA: TIGA RATUS RIBU SAHAJA) xxx tertakluk kepada syarat-syarat Jualan xxx melalui penyerahan hakkan dari Pemegang Serahak, tertakluk kepada kelulusan di perolehi oleh pihak Pembeli daripada pihak berkuasa, jika ada, termasuk semua terma, syarat xxx perjanjian yang dikenakan xxx mungkin dikenakan oleh Pihak Berkuasa yang berkenaan. Pembeli bertanggungjawab sepenuhnya untuk memperolehi xxx mematuhi syarat-syarat berkenaan daripada Pihak Berkuasa yang berkenaan, jika ada xxx semua xxx xxx perbelanjaan ditanggung xxx dibayar oleh Xxxxx Xxxxxxx.Pembeli atas talian (online) juga tertakluk kepada terma-terma xxx syarat-syarat terkandung dalam xxx.xxxxxxxxxxxxxxxx.xxx Pembeli yang berminat adalah dikehendaki mendeposit kepada Pelelong 10% daripada harga rizab dalam bentuk Bank Draf atau Cashier’s Order di atas nama RHB Bank Berhad sebelum lelongan awam xxx xxxx xxxx xxxxxx hendaklah dibayar dalam tempoh sembilan puluh (90) hari dari tarikh lelongan kepada RHB Bank Berhad melalui Bank Draf / XXXXXX. Butir-butir pembayaran melalui XXXXXX, xxxx berhubung dengan Tetuan Zahrin Emrad & Sujaihah. Untuk maklumat lanjut, xxxx berhubung dengan TETUAN ZAHRIN EMRAD & SUJIAHAH, yang beralamat di Suite 10.3, 10th Floor, Xxx Xxxx Building, Xx.00, Xxxxx Xxxx Xxxxxx, 00000 Xxxxx Xxxxxx. Tel: 00-0000 0000 / Fax: 00-0000 0000. [ Ruj: ZES/ZHR/RHB-FC/16250-17/0614-pae ], peguamcara bagi pihak pemegang xxxxx xxx atau pelelong yang tersebut dibawah.

  • Povinnosti Site and Institution’s personnel, including Study Staff shall not Místo provádění klinického hodnocení a zaměstnanci Zdravotnického zařízení, a to včetně Studijního personálu, nebudou

  • Cornerstone shall notify the LLC and confirm such advice in writing (i) when the filing of any post-effective amendment to the Registration Statement or supplement to the Prospectus is required, when the same is filed and, in the case of the Registration Statement and any post-effective amendment, when the same becomes effective, (ii) of any request by the Securities and Exchange Commission for any amendment of or supplement to the Registration Statement or the Prospectus or for additional information and (iii) of the entry of any stop order suspending the effectiveness of the Registration Statement or the initiation or threatening of any proceedings for that purpose, and, if such stop order shall be entered, Cornerstone shall use its best efforts promptly to obtain the lifting thereof.

  • Xxxxxxxxx President Secretary-Treasurer Bricklayers & Allied Craftworkers

  • Asset Management Supplier will: i) maintain an asset inventory of all media and equipment where Accenture Data is stored. Access to such media and equipment will be restricted to authorized Personnel; ii) classify Accenture Data so that it is properly identified and access to it is appropriately restricted; iii) maintain an acceptable use policy with restrictions on printing Accenture Data and procedures for appropriately disposing of printed materials that contain Accenture Data when such data is no longer needed under the Agreement; iv) maintain an appropriate approval process whereby Supplier’s approval is required prior to its Personnel storing Accenture Data on portable devices, remotely accessing Accenture Data, or processing such data outside of Supplier facilities. If remote access is approved, Personnel will use multi-factor authentication, which may include the use of smart cards with certificates, One Time Password (OTP) tokens, and biometrics.

  • Xxxxxxxx, President ACKNOWLEDGED AND ACCEPTED -------------------------

  • Managing Director 1. The Managing Director shall be appointed by the Board of Governors from among candidates having the nationality of an ESM Member, relevant international experience and a high level of competence in economic and financial matters. Whilst holding office, the Managing Director may not be a Governor or Director or an alternate of either. 2. The term of office of the Managing Director shall be five years. He or she may be re-appointed once. The Managing Director shall, however, cease to hold office when the Board of Governors so decides. 3. The Managing Director shall chair the meetings of the Board of Directors and shall participate in the meetings of the Board of Governors. 4. The Managing Director shall be chief of the staff of the ESM. He or she shall be responsible for organising, appointing and dismissing staff in accordance with staff rules to be adopted by the Board of Directors. 5. The Managing Director shall be the legal representative of the ESM and shall conduct, under the direction of the Board of Directors, the current business of the ESM.

  • Xxxxxxx, President Xxxxx X.

  • HARGA RIZAB Hartanah tersebut akan dijual “Dalam Keadaan Xxxxx Xxx” xxx tertakluk kepada satu harga rizab sebanyak RM669,000.00 (RINGGIT MALAYSIA: ENAM RATUS XXX ENAM PULUH SEMBILAN RIBU SAHAJA) xxx Syarat-syarat Jualan xxx tertakluk kepada kebenaran yang diperolehi oleh Pembeli dari Pemaju/Pemilik Tanah xxx Pihak Berkuasa yang lain, jika ada. DEPOSIT:- Semua penawar yang ingin membuat tawaran dikehendaki mendepositkan kepada Pelelong, sebelum lelongan 10% daripada harga rizab secara BANK DERAF sahaja atas nama BANK KERJASAMA RAKYAT MALAYSIA BERHAD xxx xxxx xxxx xxxxxx hendaklah dijelaskan dalam tempoh Sembilan Xxxxx (00) Hari. Bagi penawar atas talian sila rujuk Terma xxx Syarat serta cara pembayaran deposit di xxx.xxxxxxxxxxxxxxx.xxx Nota: Butir-butir hartanah adalah berdasar Laporan Penilaian xxx perjanjian-perjanjian pembiayaan yang mana berdasarkan pengetahuan kami adalah benar. Walaubagaimanapun pembida hendaklah membuat xxxxxx xxxxx atas hakmilik induk di pejabat tanah xxx/atau pihak berkuasa berkenaan. Perjanjian ini tidak akan menjadi terbatal sekiranya terdapat perbezaan berkenaan butir-butir hartanah Untuk mendapatkan butir-butir selanjutnya, xxxx berhubung dengan Tetuan Suhaimi Yahya & Co Peguamcara bagi Pihak Pemegang Serahhak/Bank di Xx. 0-0, Xxxxx Xxxxxx Xxxxxx 00, Wangsa Link, Xxxxxx Xxxx, 00000 Xxxxx Xxxxxx. (Ruj No. SY/BKRM(PJS)/LIT/010/2021/L) Tel No: 00-00000000, Fax No. 00-00000000, atau Pelelong yang tersebut di bawah ini:- Suite B-15-03, Tingkat 15, Blok B, Megan Avenue 2, (Pelelong Berlesen) 00, Xxxxx Xxx Xxxx Xxxx, 50450 Kuala Lumpur TEL NO: 00-0000000, H/P NO: 000-0000000/000-0000000 FAX NO: 00-0000000 E-mail: xxxxxxxxxxxxxxx@xxxxx.xxx Web site : xxx.xxxxxxxxxxxxxxx.xxx Rujukan kami : EZ/LACA/BKRMB/212/2021/MNS/mas

  • Executive Director (a) The HMO must employ a qualified individual to serve as the Executive Director for its HHSC HMO Program(s). Such Executive Director must be employed full-time by the HMO, be primarily dedicated to HHSC HMO Program(s), and must hold a Senior Executive or Management position in the HMO’s organization, except that the HMO may propose an alternate structure for the Executive Director position, subject to HHSC’s prior review and written approval. (b) The Executive Director must be authorized and empowered to represent the HMO regarding all matters pertaining to the Contract prior to such representation. The Executive Director must act as liaison between the HMO and the HHSC and must have responsibilities that include, but are not limited to, the following: (1) ensuring the HMO’s compliance with the terms of the Contract, including securing and coordinating resources necessary for such compliance; (2) receiving and responding to all inquiries and requests made by HHSC related to the Contract, in the time frames and formats specified by HHSC. Where practicable, HHSC must consult with the HMO to establish time frames and formats reasonably acceptable to the Parties; (3) attending and participating in regular HHSC HMO Executive Director meetings or conference calls; (4) attending and participating in regular HHSC Regional Advisory Committees (RACs) for managed care (the Executive Director may designate key personnel to attend a RAC if the Executive Director is unable to attend); (5) making best efforts to promptly resolve any issues identified either by the HMO or HHSC that may arise and are related to the Contract; (6) meeting with HHSC representative(s) on a periodic or as needed basis to review the HMO’s performance and resolve issues, and (7) meeting with HHSC at the time and place requested by HHSC, if HHSC determines that the HMO is not in compliance with the requirements of the Contract.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!